The blunted weight-reducing effect of intracerebroventricular administered acyl-GIP in the brain-specific GIPR knockout mice indicates that the anti-obesity effect of GIP or the GIPR system is mediated via GIPR in the CNS. The gene discussed is GIPR; the disease is obesity disorder.